Alligator Bioscience AB
STO:ATORX

Watchlist Manager
Alligator Bioscience AB Logo
Alligator Bioscience AB
STO:ATORX
Watchlist
Price: 0.0076 SEK Market Closed
Market Cap: 130m SEK
Have any thoughts about
Alligator Bioscience AB?
Write Note

Wall Street
Price Targets

ATORX Price Targets Summary
Alligator Bioscience AB

Wall Street analysts forecast ATORX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATORX is 0.0306 SEK with a low forecast of 0.0303 SEK and a high forecast of 0.0315 SEK.

Lowest
Price Target
0.0303 SEK
299% Upside
Average
Price Target
0.0306 SEK
303% Upside
Highest
Price Target
0.0315 SEK
314% Upside
Alligator Bioscience AB Competitors:
Price Targets
FLUO
Fluoguide AS
187% Upside
2315
Biocytogen Pharmaceuticals Beijing Co Ltd
0% Upside
251120
Bio-FD&C Co Ltd
49% Upside
DVYSR
Devyser Diagnostics AB
70% Upside
IDYA
IDEAYA Biosciences Inc
203% Upside
RPTX
Repare Therapeutics Inc
430% Upside
2616
CStone Pharmaceuticals
25% Downside
4593
Healios KK
38% Upside

Revenue
Forecast

Revenue Estimate
Alligator Bioscience AB

For the last 8 years the compound annual growth rate for Alligator Bioscience AB's revenue is 0%. The projected CAGR for the next 2 years is 17%.

0%
Past Growth
17%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Alligator Bioscience AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Alligator Bioscience AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-91%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATORX's stock price target?
Price Target
0.0306 SEK

According to Wall Street analysts, the average 1-year price target for ATORX is 0.0306 SEK with a low forecast of 0.0303 SEK and a high forecast of 0.0315 SEK.

What is Alligator Bioscience AB's Revenue forecast?
Projected CAGR
17%

For the last 8 years the compound annual growth rate for Alligator Bioscience AB's revenue is 0%. The projected CAGR for the next 2 years is 17%.

Back to Top